How Cheap Can Gilead Sciences (GILD) Get?

With the self-destruction of Donald Trump’s presidential campaign, it seems like the market is pricing in a Hillary Clinton presidential win come November 8th. In particular, the biotech and major pharmaceutical companies have been smashed over the past half year, with some stocks like Gilead losing almost 30% in this short period of time. While…

Continue Reading →